<DOC>
	<DOCNO>NCT01248325</DOCNO>
	<brief_summary>Sixty subject take part study . The subject randomly assign 1:1 ratio two arm study . ( Group A : Solution Luffa Nasal Operculate 5mg/mL , Group B : saline ) . The subject use study medication comparative , accord randomization , treatment period 3 7 day . A follow-up visit make 15 day initiation treatment .</brief_summary>
	<brief_title>A Study Luffa Operculate Nasal Solution 5mg/mL Compared With Saline ( NaCl 09 % ) Relief Nasal Obstruction</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Nasal Obstruction</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Subjects sex age 18 year . Presence nasal congestion due cold , rhinitis , influenza , sinusitis acute chronic sinusitis Sign Informed Consent Form Comply study requirement attend study visit Female subject must NEGATIVE urine pregnancy test screening . Known allergy study product component Subject pregnant , lactate childbearing potential use adequate effective contraceptive Vasoconstrictor nasal topic oral Use decongestant nasal whatever route administration Use intranasal corticosteroid Use antiallergic Use medication contain atropine Subjects participate another study participate another study , less 12 month Any subject deem unsuitable study Principal Investigator Abuse alcohol illicit drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>